Skip to main contentSkip to navigation
Sirius Investors
Liminatus Pharma, Inc. Class A Common Stock

Liminatus Pharma, Inc. Class A Common Stock

LIMN
NASDAQHealthcare

Insider Trading for LIMN

View recent insider trading activity including purchases, sales, and awards. Insider trading can provide insights into how executives view their company's prospects.

Insider Trading Summary

Shares Acquired
Sign in to see amounts
Shares Disposed
Sign in to see amounts
Net Position
Sign in to see net activity
Unlock for free

Already registered? Sign in

Recent Activity (30 Days)

Acquisitions: 3.4M shares
Dispositions: 0 shares
Net: 3.4M shares

Insiders have been net buyers recently, potentially signaling confidence in the company's short-term prospects.

Quarterly Activity (3 Months)

Acquisitions: 3.4M shares
Dispositions: 4.4M shares
Net: -924.7K shares

Insiders have been net sellers over the quarter, which institutional investors may view as a cautionary signal.

Key Insider Activity: Apr 30, 2025 to Jul 2, 2026

Valetudo Therapeutics LLC
Other10 Percent Owner
-924.7K shares
3 transactions
Ewon Comfortech Co., Ltd.
Other10 Percent Owner
0 shares
1 transactions
Iris Acquisition Holdings LLC
Other10 Percent Owner
0 shares
1 transactions
Lemons II Philip Wayne
DirectorDirector:
0 shares
1 transactions
Baek Richard JaiHwan
DirectorDirector:
0 shares
1 transactions

Transaction Details

DateInsiderRoleTransactionSharesPriceValueOwned AfterSEC Filing
Jul 2, 2026Valetudo Therapeutics LLC10 Percent OwnerJ-Other3.4M$0.20$689,785.205.2MView
Jun 24, 2026Valetudo Therapeutics LLC10 Percent OwnerJ-Other4.4M$0.00$0.001.8MView
Jun 24, 2026Ewon Comfortech Co., Ltd.10 Percent OwnerUnknown0$0.00$0.005.5MView
Jul 10, 2025
Locked
Jul 10, 2025
Locked
Apr 30, 2025
Locked
Apr 30, 2025
Locked
Apr 30, 2025
Locked
Apr 30, 2025
Locked
Apr 30, 2025
Locked
Apr 30, 2025
Locked
Apr 30, 2025
Locked
Apr 30, 2025
Locked
Apr 30, 2025
Locked
Apr 30, 2025
Locked
Apr 30, 2025
Locked
Click "View" in the SEC Filing column to access the detailed SEC form submission for each transaction.

Executive Activity:

Executives have been net sellers of LIMN stock, though this may be part of planned diversification.